Celltrion Eyes M&A, Global Expansion And Novel Drugs As Founder Returns

 
• By Jung Won Shin

Celltrion founder and chairman Jung Jin Seo has outlined why he has decided to return to the Korean biosimilars major and the business priorities for the group if it is to emerge as a top-tier global biopharma operation.

Celltrion Group Chairman Jung Jin Seo
Crucial Time For Celltrion’s Expansion In Global Territories • Source: Celltrion Group

More from Strategy

More from Business